Rephonic
Artwork for Oncology Today

Oncology Today with Dr Neil Love

Dr. Neil Love
Ovarian Cancer
Antibody-Drug Conjugates
Clinical Trials
Biliary Tract Cancers
PARP Inhibitors
Chronic Lymphocytic Leukemia
Myelofibrosis
Gastroesophageal Cancers
Immunotherapy
Bevacizumab
Ruxolitinib
Lung Cancer
Myelodysplastic Syndromes
Acute Myeloid Leukemia
CA125
Palabresib
Pd-L1 Inhibitors
Gynecologic Oncology
Hepatobiliary Cancers
Venetoclax

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

PublishesDailyEpisodes398Founded6 years ago
Number of ListenersCategories
MedicineHealth & FitnessScience

Listen to this Podcast

Artwork for Oncology Today

Latest Episodes

Dr Natalie Vokes from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of lung cancer.

CME information and select publications here.

YouTube

Dr Seth Wander from Massachusetts General Hospital in Boston discusses the role of biomarker assessment in the management of HR-positive metastatic breast cancer.

CME information and select publications here.

YouTube

Dr Matthew Milowsky from the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, comments on real patient cases of metastatic urothelial bladder cancer presented by Dr Jacqueline T Brown from the Emory University School of Medi... more

YouTube

Dr Virginia F Borges from the University of Colorado Anschutz Medical Campus in Aurora and Dr Ian E Krop from Yale Cancer Center in New Haven, Connecticut, review clinical research data and best practices guiding the selection of first-line and maint... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Dr. Natalie Vokes
From MD Anderson Cancer Center, Houston
MD Anderson Cancer Center
Episode: Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
Dr Seth Wander
Medical oncologist, Massachusetts General Hospital, Boston
Massachusetts General Hospital
Episode: HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making
Matt Milowsky
Urologic medical oncologist
University of North Carolina, Lineberger Comprehensive Cancer Center
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 4
Virginia Borges
Oncologist at University of Colorado Anschutz Medical Campus
University of Colorado Anschutz Medical Campus
Episode: ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy
Ian Krop
Oncologist at Yale Cancer Center
Yale Cancer Center
Episode: ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy
Stacey Cohen
Faculty presenter on CT DNA testing in localized colorectal cancer
Fred Hutchinson Cancer Center, University of Washington
Episode: Localized Colorectal Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Dr. Paul Richardson
Dana-Farber Cancer Institute, expert in multiple myeloma
Dana-Farber Cancer Institute
Episode: CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson
Ravin Ratan
From MD Anderson Cancer Center, commentator on desmoid case series
MD Anderson Cancer Center
Episode: Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan
Sam Klempner
Moderator and faculty member
Massachusetts General Hospital
Episode: Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Host

Dr Neil Love
Medical oncologist specializing in oncology practice and research.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#88
Saudi Arabia/Science
Apple Podcasts
#101
Austria/Science
Apple Podcasts
#239
South Korea/Science

Talking Points

Recent interactions between the hosts and their guests.

Localized Colorectal Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Q: Would you consider skipping chemotherapy entirely and using immunotherapy for certain patients with MSI-high or poli-mutant tumors?
There is cautious consideration for immunotherapy in select MSI-high patients, especially when CTDNA suggests minimal disease burden, but overall consensus emphasizes careful patient selection and recognizing that definitive evidence supporting universal omission of chemotherapy is lacking; some experts would opt for immunotherapy in specific high-risk elderly patients or CTDNA-positive cases, but not as a broad replacement.
Localized Colorectal Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Q: What are some of the clinical pathologic features that most strongly influenced your recommendation for adjuvant therapy in MSI-high disease?
The panel indicates that MSI-high status, T4 features, and overall TNM context shape adjuvant decisions, with consideration of the tumor's biology and the potential toxicity of chemotherapy, and whether CTDNA negative status might sway toward less aggressive adjuvant chemotherapy in some cases, though the default remains to offer standard therapy unless clear biomarkers suggest otherwise.
CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson
Q: In practice, how would you sequence iberdomide and mezigdomide with existing therapies for relapsed myeloma?
Iberdomide is favored early and as maintenance due to lower second primary cancer risk and tolerability, while mezigdomide may address heavily pre-treated relapse-refractory patients, providing flexibility based on patient biology and prior exposures.
CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson
Q: How do you envision MRD being used in regulatory decisions for these new agents?
MRD is viewed as a meaningful surrogate that can reflect deeper responses and potential long-term benefit, guiding accelerated or conditional approvals while awaiting mature survival data.
Nonmelanoma Skin Cancers — A Roundtable Discussion on the Multidisciplinary Management of Cutaneous Squamous Cell and Basal Cell Carcinomas
Q: What is the role of neoadjuvant PD-1 therapy in resectable CSCC?
Neoadjuvant anti-PD-1 therapy can induce high pathologic complete responses and major pathologic responses, suggesting potential for downstaging and better disease control, though radiographic responses may underestimate pathologic benefit.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Oncology Today

What is Oncology Today about and what kind of topics does it cover?

Content focuses primarily on the latest advancements in oncology, featuring in-depth discussions between a medical oncologist and clinical investigators. Key topics include treatment protocols for various cancers, insights from recent clinical trials, and expert commentary on emerging therapies and practices. Noteworthy is the emphasis on personalized treatment strategies and the evolving landscape of therapies across multiple oncology domains, including bladder, prostate, and gynecologic cancers. Episodes highlight significant findings from major conferences that guide current clinical practices, making it a valuable resource for healthcare professionals seeking to stay updated on oncology innovations.

Where can I find podcast stats for Oncology Today?

Rephonic provides a wide range of podcast stats for Oncology Today. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oncology Today and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Oncology Today get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Oncology Today, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Oncology Today?

Rephonic provides comprehensive predictive audience data for Oncology Today, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Oncology Today have?

To see how many followers or subscribers Oncology Today has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Oncology Today?

These podcasts share a similar audience with Oncology Today:

1. Two Onc Docs
2. Research To Practice | Oncology Videos
3. Oncology Brothers: Practice-Changing Cancer Discussions
4. Breast Cancer Update
5. Hematologic Oncology Update

How many episodes of Oncology Today are there?

Oncology Today launched 6 years ago and published 398 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Oncology Today?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Oncology Today?

Rephonic pulls ratings and reviews for Oncology Today from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Oncology Today?

Rephonic provides full transcripts for episodes of Oncology Today. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Oncology Today?

Recent guests on Oncology Today include:

1. Dr. Natalie Vokes
2. Dr Seth Wander
3. Matt Milowsky
4. Virginia Borges
5. Ian Krop
6. Stacey Cohen
7. Dr. Paul Richardson
8. Ravin Ratan

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days